000			01710 a2200457 4500
005			20250518022004.0
264		0	_c20200729
008			202007s 0 0 eng d
022			_a1460-2091
024	7		_a10.1093/jac/dky560 _2doi
040			_aNLM _beng _cNLM
100	1		_aPascua, Philippe Noriel Q
245	0	0	_aOptimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model. _h[electronic resource]
260			_bThe Journal of antimicrobial chemotherapy _c05 2019
300			_a1333-1341 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
650	0	4	_aAdministration, Oral
650	0	4	_aAmides _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aDisease Models, Animal
650	0	4	_aDogs
650	0	4	_aEpithelial Cells _xvirology
650	0	4	_aFemale
650	0	4	_aImmunocompromised Host
650	0	4	_aInfluenza B virus _xdrug effects
650	0	4	_aMadin Darby Canine Kidney Cells
650	0	4	_aMice
650	0	4	_aMice, Inbred BALB C
650	0	4	_aMice, SCID
650	0	4	_aOrthomyxoviridae Infections _xdrug therapy
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aViral Load _xdrug effects
650	0	4	_aVirus Replication _xdrug effects
700	1		_aMarathe, Bindumadhav M
700	1		_aVogel, Peter
700	1		_aWebby, Richard J
700	1		_aGovorkova, Elena A
773	0		_tThe Journal of antimicrobial chemotherapy _gvol. 74 _gno. 5 _gp. 1333-1341
856	4	0	_uhttps://doi.org/10.1093/jac/dky560 _zAvailable from publisher's website
999			_c29325031 _d29325031